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ABSTRACT
Chorea is usually associated with neurological diseases. However, it can also be seen in patients with systemic lupus erythematosus (SLE), rheumatic 
fever (Sydenham’s chorea), polycythemia vera, and thyrotoxicosis. Here, we report an interesting case of hemichorea in a 32-year-old lady, who 
presented with acute onset of jerky, non-repetitive involuntary movements of the left upper and lower limbs. After detailed evaluation, she was found 
to have thyrotoxicosis. Thyroid Tc-scan showed diffuse uptake suggesting Grave’s disease. A magnetic resonance imaging of the brain was normal. 
Other causes of chorea like SLE and rheumatic fever were excluded. She was started on carbimazole. On follow-up after 6 weeks of therapy, there was 
the complete disappearance of chorea, and her thyroid hormone levels were normal.
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INTRODUCTION
Chorea is usually a feature that is closely associated with the nervous 
system. People affected by this condition show dancing movements, 
commonly of the limbs. Even though it is distressing to the patient, it is 
not a dangerous condition [1]. Chorea is seen in many conditions such 
as APLA syndrome, Huntington’s disease, rheumatic fever (Sydenham’s 
chorea), systemic lupus erythematosus [2]. Chorea due to thyrotoxicosis 
was the first described in 1893 by Sir William Gowers [3]. There have 
been a few reports published in the past where patients presented with 
chorea due to thyrotoxicosis. This is one such report of a patient that we 
encountered in our hospital.
CASE REPORT
A 32-year-old lady presented with a history of abnormal movements of 
left upper and lower limbs. There was no history suggestive of motor 
weakness or sensory involvement. Her speech was normal. There was 
no history of a headache, seizures, rashes, or joint pain. On examination, 
she was completely conscious, had a tachycardia of 120 beats/min with 
a blood pressure of 120/80 mm of Hg. Ophthalmic examination was 
normal. She had violent choreiform movements of the left upper and 
lower limbs. Otherwise, her neurological examination was normal. The 
examination of other systems was within normal limits.
Hematological investigations showed a pattern of iron deficiency anemia. 
Renal function tests, liver function tests, and copper studies were normal. 
MRI of the brain was also normal. ASO titer was within normal limits, 
thus excluding streptococcal origin. ANA was negative. Thyroid function 
tests done showed T3 of 3.68 IU/ml, T4 of 16.35 IU/ml and thyroid 
stimulating hormone of <0.005 mIU/ml (indicating hyperthyroidism). 
Anti-TPO antibody levels were high 357.6 IU/ml. Thyroid Tc-scan done 
showed diffuse uptake by the thyroid gland, confirming thyrotoxicosis. 
She was treated with carbimazole for the same. 6 weeks later, when the 
patient turned up for a review, she was completely asymptomatic, and 
her thyroid hormone levels were normal.
DISCUSSION
Chorea is associated with a variety of disease states, indicating that 
this extrapyramidal syndrome has several factors associated to its 
pathophysiology. In Huntington’s chorea, the neuronal damage is found 
in the striatum, whereas chorea in thyrotoxicosis is thought to be more 
of biochemical in origin, rather than being structural [4]. In all forms 
of chorea, it has been observed that dopamine agonists will produce 
exacerbation while dopamine antagonists ameliorate the condition. 
The mechanism of thyrotoxicosis causing chorea is hypothesized to 
be due to increased sensitivity of dopaminergic receptor sites in the 
corpus striatum. Klawans and Shenker have also shown that turnover 
of dopamine is lowered in hyperthyroid patients as a reflection 
of hypersensitivity of dopaminergic receptors [5]. Case reports of 
thyrotoxic chorea have noted rapid response to beta-blockers and 
dopamine antagonists given along with anti-thyroid drugs [6,7]. In our 
case, we had excluded most of the other causes of chorea and the fact 
that she improved after achieving euthyroid state gave us a strong clue 
that the chorea was secondary to thyrotoxicosis.
CONCLUSION
To conclude, chorea or hemichorea may be one of the primary features 
of thyrotoxicosis although this is a rare scenario. Once a patient with 
chorea walks into the clinic, the clinician almost always jumps to the 
conclusion that the patient has a sole neurological disorder. It should be 
kept in mind that there are other causes for chorea, and thyrotoxicosis 
(a medical emergency) is one of them.
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